Global point of care
This webinar highlights the devastating impact that tuberculosis (TB) disease continues to have across the globe and highlights the important role that point-of-care (POC) diagnostic tests such as urine lipoarabinomannan (LAM) can play in diagnosing active TB infections.
Doug Wilson, PHD, FCP, MBCHB
Department of Internal Medicine, Harry Gwala Regional Hospital
University of KwaZulu-Natal, South Africa
Paul Drain, MD, MPH
Director, Clinical and Translational Science Core, SEATRAC Associate Professor, Departments of Global Health, Medicine, and Epidemiology
University of Washington, Seattle
Physicians treating TB patients
A LEADER IN RAPID POINT-OF-CARE DIAGNOSTICS.
©2025 Abbott. All rights reserved. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.
This website is governed by applicable U.S. laws and governmental regulations. The products and information contained herewith may not be accessible in all countries, and Abbott takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage.
Your use of this website and the information contained herein is subject to our Website Terms and Conditions and Privacy Policy. Photos displayed are for illustrative purposes only. Any person depicted in such photographs is a model. GDPR Statement.
Not all products are available in all regions. Check with your local representative for availability in specific markets. For in vitro diagnostic use only. For i-STAT test cartridge information and intended use, refer to individual product pages or the cartridge information (CTI/IFU) in the i-STAT Support area.
Abbott - A Leader in Rapid Point-of-Care Diagnostics.
